Home › GlaxoSmithKline's COPD drug Anoro receives European green light
 

Keywords :   


GlaxoSmithKline's COPD drug Anoro receives European green light

2014-02-20 19:26:31| Biotech - Topix.net

Anoro, a combination drug for chronic obstructive pulmonary disease developed by GlaxoSmithKline and Theravance, has received the green light from European regulators, the companies said on Thursday.

Tags: light green drug european

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.09Mortgages at six times' income for first-time buyers
23.09Tropical Storm John Graphics
23.09Tropical Storm John Public Advisory Number 3A
23.09Summary for Tropical Storm John (EP5/EP102024)
23.09Eastern North Pacific Tropical Weather Outlook
23.09Atlantic Tropical Weather Outlook
23.09Are your barns winter ready?
23.09Emerging Pork Leaders Carolina now accepting applications
More »